Skip to search formSkip to main contentSkip to account menu

erbstatin

Known as: Formamide, N-(2-(2,5-dihydroxyphenyl)ethenyl)-, (E)- 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Enzyme InhibitorsHydroquinones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2001
2001
Lipid peroxidation product 4-hydroxy-2-nonenal acts synergistically with serotonin in inducing vascular smooth muscle cell proliferation.
Highly Cited
1999
Highly Cited
1999
Cell Volume-dependent Regulation of L-selectin Shedding in Neutrophils
Neutrophil-mediated organ damage is a common feature of many disease states. We previously demonstrated that resuscitation with… 
Highly Cited
1997
Highly Cited
1997
Differential effects of tyrosine kinase inhibitors and an inhibitor of the mitogen-activated protein kinase cascade on degranulation and superoxide production of human neutrophil granulocytes.
Highly Cited
1996
Highly Cited
1996
Involvement of hydrogen peroxide production in erbstatin-induced apoptosis in human small cell lung carcinoma cells.
Tyrosine kinase inhibitor, erbstatin, induced morphological apoptosis and DNA fragmentation in human small cell lung carcinoma… 
1994
1994
Vanadate stimulates differentiation and neurite outgrowth in rat pheochromocytoma PC12 cells and neurite extension in human neuroblastoma SH-SY5Y cells
Highly Cited
1992
Highly Cited
1992
Tyrosine phosphorylation and its possible role in superoxide production by human neutrophils stimulated with FMLP and IgG.
1992
1992
Granulocyte-macrophage colony-stimulating factor primes phospholipase D activity in human neutrophils in vitro: role of calcium, G-proteins and tyrosine kinases.
Highly Cited
1990
Highly Cited
1990
Selective inhibition of human neutrophil functional responsiveness by erbstatin, an inhibitor of tyrosine protein kinase.
The role of tyrosine kinases in the responses of human neutrophils to chemotactic factors was examined using the recently… 
1987
1987
Antitumor activity of erbstatin, a tyrosine protein kinase inhibitor.
A tyrosine protein kinase inhibitor, erbstatin, showed no antineoplastic effect on L-1210 mouse leukemia when it was injected… 
1987
1987
Inhibition of tyrosine protein kinase by synthetic erbstatin analogs.
Sir: The effective synthesis of the specific tyrosine protein kinase (TPK) inhibitor, erbstatin (1), and its dihydroxy analogs… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)